KactusBio Inc.

Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control Protein (MHC-HM40C)

Product Code:
 
KAC-MHC-HM40C
Product Group:
 
MHC Monomers
Supplier:
 
KactusBio Inc.
Regulatory Status:
 
RUO
Target Species:
 
Human
Shipping:
 
Shipped at ambient temperature.
Storage:
 
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
1 / 2
Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control on Bis-Tris PAGE under reduced condition. The purity is greater than 95%
2 / 2
The purity of Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control is greater than 95% as determined by SEC-HPLC.
❮❯

Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control on Bis-Tris PAGE under reduced condition. The purity is greater than 95%
The purity of Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control is greater than 95% as determined by SEC-HPLC.

No additional charges, what you see is what you pay! *

CodeSizePrice
KAC-MHC-HM40C-100UG100UG£327.00
Quantity:
KAC-MHC-HM40C-500UG500UG£974.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Background:
HLA-E is a nonclassical member of the major histocompatibility complex class I gene locus. HLA-E protein shares a high level of homology with MHC Ia classical proteins: it has similar tertiary structure, associates with β2-microglobulin, and is able to present peptides to cytotoxic lymphocytes. The main function of HLA-E under normal conditions is to present peptides derived from the leader sequences of classical HLA class I proteins, thus serving for monitoring of expression of these molecules performed by cytotoxic lymphocytes.
Biotinylated:
no
Description:
Recombinant Human HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control Protein is expressed from HEK293 with His tag and Avi at the C-Terminus.It contains Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPKTLVL peptide.
Endotoxin:
Less than 1EU per ug by the LAL method.
Exact Sequence:
Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPKTLVL peptide
Expression System:
HEK293
Form:
Lyophilized
Formulation:
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Gene/Protein ID:
P13747(HLA-E*01:03)&P61769(B2M)&VMAPKTLVL
Molecular Weight:
The protein has a predicted MW of 50.2 kDa. Due to glycosylation, the protein migrates to 52-62 kDa based on Bis-Tris PAGE result.
Purity:
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
Reconstitution:
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.
Tag:
C-His-Avi
Target:
HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control

Documents